|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5200 USD | -5.42% |
|
-1.16% | -59.69% |
| Market Cap | 17.38M 15.22M 14.02M 13.01M 24.71M 1.66B 25.04M 168M 65.3M 814M 65.25M 63.82M 2.82B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 17.38M 15.22M 14.02M 13.01M 24.71M 1.66B 25.04M 168M 65.3M 814M 65.25M 63.82M 2.82B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
98.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Pasithea Therapeutics Corp.
| 1 day | -5.42% | ||
| 1 week | -1.16% | ||
| Current month | +0.89% | ||
| 1 month | -11.11% | ||
| 3 months | -34.43% | ||
| 6 months | -51.85% | ||
| Current year | -59.69% |
| 1 week | 0.5 | 0.61 | |
| 1 month | 0.47 | 0.61 | |
| Current year | 0.47 | 1.28 | |
| 1 year | 0.28 | 2.06 | |
| 3 years | 0.28 | 17.4 | |
| 5 years | 0.28 | 170 | |
| 10 years | 0.28 | 170 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tiago Marques
CEO | Chief Executive Officer | 49 | 2020-07-31 |
| Director of Finance/CFO | 48 | 2022-10-10 | |
Kartik Krishnan
CTO | Chief Tech/Sci/R&D Officer | 55 | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | - | |
Tiago Marques
BRD | Director/Board Member | 49 | 2020-07-31 |
Simon Dumesnil
BRD | Director/Board Member | 49 | 2021-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-30 | Free | Chief Financial Officer | 1,129,323 | 4.5282% | ||
| 04-30 | Free | Founder | 152,783 | 0.6126% | ||
| 04-30 | Free | Director | 152,783 | 0.6126% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.42% | -1.16% | -28.98% | -94.90% | 18.37M | ||
| -2.14% | +3.51% | +74.05% | +131.10% | 59.1B | ||
| -0.93% | -2.54% | +73.64% | +93.71% | 55.19B | ||
| -3.71% | -0.35% | -14.61% | -11.19% | 24.67B | ||
| -0.05% | +6.49% | +14.05% | +451.36% | 24.19B | ||
| -0.48% | +8.79% | +50.26% | -0.42% | 19.69B | ||
| -2.19% | +6.34% | +40.74% | -29.60% | 17.56B | ||
| +3.58% | +13.78% | +196.41% | +348.55% | 16.22B | ||
| +0.38% | +20.82% | +49.55% | - | 14.84B | ||
| -0.57% | +2.30% | +20.33% | +187.27% | 14.04B | ||
| Average | -1.12% | +7.16% | +47.54% | +119.54% | 24.55B | |
| Weighted average by Cap. | -1.05% | +5.66% | +58.37% | +135.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
5
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | US$0.5200 | -5.42% | 320,543 |
| 26-07-02 | US$0.5498 | -3.02% | 421,790 |
| 26-07-01 | US$0.5669 | +9.99% | 1,428,472 |
| 26-06-30 | US$0.5154 | -2.03% | 25,950,553 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5200USD
Average target price
3.000USD
Spread / Average Target
+476.92%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KTTA Stock
Select your edition
All financial news and data tailored to specific country editions

















